Iran Emerges as World’s Second-Largest Producer of Innovative ‘Tilmanocept’ Cancer Tracer

Iran Emerges as World’s Second-Largest Producer of Innovative ‘Tilmanocept’ Cancer Tracer

In a groundbreaking achievement, an Iranian knowledge-based company has developed a new method for synthesizing Technetium (99mTc) tilmanocept, a crucial radiopharmaceutical diagnostic imaging agent. This innovative product is designed to aid in the identification of lymph nodes that may be draining from tumors, significantly impacting cancer treatment strategies.

Since 2013, the United States has stood as the sole manufacturer of this vital radiopharmaceutical agent, as reported by IRNA. The lymphatic system plays a critical role in cancer metastasis, making accurate detection of lymph node involvement essential for effective surgical intervention, particularly in patients diagnosed with breast, lung, and genital tract cancers.

Without timely identification of affected lymph nodes, surgeons may resort to removing large sections of the lymphatic system. This invasive procedure can lead to numerous side effects and severely compromise a patient’s immune system and blood circulation. The newly developed radiodiagnostic agent will assist healthcare professionals in pinpointing lymph nodes for removal, thus preserving healthy lymphatic tissue and reducing unnecessary surgeries and complications.

Thanks to this remarkable advancement, approximately 90 percent of cancer patients in Iran will have access to a more affordable and accurate diagnostic and treatment method. The drug has successfully progressed through preclinical phases and is now in the clinical trial stage.

Cancer remains one of the most pressing global health challenges, impacting millions of individuals each year. According to the Iranian Health Ministry, cancers are the leading cause of premature mortality in the country, contributing to over 55,000 deaths annually. Of these, around 34,000 deaths occur among those under 70 years, and 11,000 among those under 50 years of age, resulting from various cancer types.

The latest national cancer census indicates a concerning trend, with new cancer cases in Iran projected to rise to 160,000 by the Iranian calendar year 1404 (March 2025-March 2026), representing a 43 percent increase. The ten most common cancers in Iran include:

  • Breast Cancer
  • Prostate Cancer
  • Colon Cancer
  • Stomach Cancer
  • Lung Cancer
  • Bladder Cancer
  • Thyroid Cancer
  • Uterine Cancer
  • Brain Cancer
  • Spinal Cancer

For Iranian women, the most prevalent cancers consist of:

  • Breast Cancer
  • Colon Cancer
  • Thyroid Cancer
  • Stomach Cancer
  • Uterine Cancer
  • Leukemia
  • Ovarian Cancer
  • Brain Cancer
  • Spinal Cancer
  • Lung Cancer
  • Esophageal Cancer

Currently, around 250,000 Iranians are living with cancer. It is noteworthy that nearly half of all cancers can be treated effectively, while the remainder can often be prevented.

Recent Achievements in Cancer Research

On January 20, 2024, the Iran University of Medical Sciences (IUMS) announced the development of an artificial intelligence (AI)-based system capable of detecting breast cancer with a remarkable 94 percent accuracy, as reported by IRNA. Breast cancer is the second leading cause of mortality among women in Iran, with approximately 30 percent of patients succumbing to the disease each year, aligning closely with the global average.

Early detection is crucial as it significantly enhances the chances of successful treatment and survival. In addition, an Iranian knowledge-based company has expressed readiness to fulfill the demand for the human papillomavirus (HPV) vaccine across regional countries and North Africa. This vaccine is essential as HPV is a known cause of cervical cancer in women.

The HPV vaccine has been produced at a substantially reduced cost, being 75 percent cheaper than foreign alternatives. Manufacturing the HPV vaccine involves one of the most intricate technologies globally, yet Iran has successfully developed this vaccine domestically. Following rigorous safety and efficacy trials, the vaccine received approval from the Food and Drug Organization in 2020.

In a notable achievement for cancer treatment, an Iranian knowledge-based company successfully produced ibrutinib, a medication used to treat various blood cancers, positioning Iran as the third country in the world capable of producing this advanced treatment. Now, Iran joins India and China as the only nations with the expertise to manufacture ibrutinib and its necessary raw materials, according to IRNA.

These advancements in cancer treatment and diagnosis signify a pivotal moment for healthcare in Iran, promising better outcomes for patients and a brighter future in the fight against cancer.

Similar Posts

  • Iran’s West Azarbaijan Achieves Remarkable 2.7 Million Tons in Exports Over 10 Months

    West Azarbaijan province has experienced significant growth in non-oil exports, with a remarkable 63% increase in volume and value from March 21, 2024, to January 20, 2025. A total of 2.7 million tons of goods valued at approximately $1.6 million were exported, while customs revenue surged by 88%. Customs Office Observer Khaled Jangjoo attributed this growth to improved trade policies, infrastructure, and international partnerships, fostering a favorable business environment. This transformation is not only beneficial for local businesses and job creation but also positions West Azarbaijan as a key player in the non-oil sector, promising sustained economic development.

  • Iran and US Set to Negotiate Groundbreaking Deal: Exploring Acceptable Terms for Cooperation

    Amid rising tensions, negotiations regarding Iran’s nuclear program are progressing, with both sides exploring potential agreements contingent on a more constructive U.S. stance. Iranian Foreign Minister Abbas Araghchi emphasized the importance of direct dialogue, asserting that while uranium enrichment discussions are possible, the principle of enrichment is non-negotiable. The inaugural talks in Oman were described as constructive, with both nations committing to future consultations. As the global community watches, there is cautious optimism for a resolution that could enhance regional stability and reshape international relations, contingent on both parties’ willingness to compromise and engage constructively.

  • Iran Joins 21st APPCED: Pioneering Climate Resilience Initiatives

    An Iranian delegation, led by MP Somayyeh Rafiei, attended the 21st Asia-Pacific Parliamentarians Conference on Environment and Development (APPCED) in South Korea on September 23, focusing on “Together, for Climate Resilience.” The conference aimed to promote regional partnerships, empower parliamentary leadership, and address climate change, especially for vulnerable nations. Rafiei met with South Korean Speaker Woo Won-shik to discuss enhancing cooperation on environmental issues. Established in 1993, APPCED facilitates dialogue among member states to tackle sustainable development challenges. The need for environmental diplomacy was emphasized, particularly regarding shared resources and climate impacts affecting multiple nations.

  • Iran and Qatar Strengthen Ties: Foreign Ministers Meet in Doha

    Iran’s Foreign Minister Abbas Araqchi met Qatar’s Prime Minister and Foreign Minister Mohammed bin Abdulrahman bin Jassim Al Thani in Doha to discuss enhancing bilateral relations and addressing key regional issues. Their discussions focused on strategies to strengthen Iran-Qatar interactions, the humanitarian crisis in Gaza, and collaboration to support the Palestinian people. Araqchi also updated on indirect negotiations between Iran and the U.S. His visit coincided with the fourth Iran-Arab World Dialogue Summit, aimed at fostering better relations and understanding among leaders, emphasizing the importance of dialogue for regional cooperation.

  • Iran’s Destiny at the 2025 Beach Soccer World Cup: What Lies Ahead?

    The FIFA Beach Soccer World Cup Seychelles 2025 is set to begin on May 1, featuring top teams competing for the title. Team Melli is in Group B with Portugal, Mauritania, and Paraguay, while host Seychelles will face Belarus, Guatemala, and Japan in Group A. The tournament, concluding on May 11, promises thrilling matches and showcases both established and emerging teams. Notably, Group D includes a rematch between Brazil and Italy from the previous final. The event also emphasizes cultural exchanges and aims to boost the sport’s global popularity. Fans are encouraged to support their teams during this exciting spectacle.

  • Iran Slams Israel’s Assault on Yemeni Ports as a ‘War Crime’

    Iran’s Foreign Ministry spokesperson, Esmaeil Baqaei, condemned recent Israeli airstrikes on Yemeni ports, characterizing them as warmongering and a violation of international law. He emphasized that these attacks exacerbate Yemen’s humanitarian crisis and amount to war crimes. Baqaei accused the U.S., Britain, and other Western nations of complicity in Israeli aggression, asserting that their support emboldens such actions against vulnerable populations, including Palestinians and Yemenis. He criticized the U.N. Security Council for its inaction, urging the Islamic world to unite against Israeli expansionism to ensure regional and global peace.